Repp et al., 2024 - Google Patents
Opportunities and challenges in catheter-based irreversible electroporation for ventricular tachycardiaRepp et al., 2024
View HTML- Document ID
- 14947380966959472826
- Author
- Repp M
- Chinyere I
- Publication year
- Publication venue
- Pathophysiology
External Links
Snippet
The use of catheter-based irreversible electroporation in clinical cardiac laboratories, termed pulsed-field ablation (PFA), is gaining international momentum among cardiac electrophysiology proceduralists for the non-thermal management of both atrial and …
- 206010047302 ventricular tachycardia 0 title abstract description 125
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
- A61B5/0402—Electrocardiography, i.e. ECG
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Camacho et al. | Large mammalian animal models of heart disease | |
| Heckman et al. | Comparing ventricular synchrony in left bundle branch and left ventricular septal pacing in pacemaker patients | |
| Avazzadeh et al. | Establishing irreversible electroporation electric field potential threshold in a suspension in vitro model for cardiac and neuronal cells | |
| Ivanovski et al. | Biventricular versus conduction system pacing after atrioventricular node ablation in heart failure patients with atrial fibrillation | |
| Bacharova | Missing link between molecular aspects of ventricular arrhythmias and QRS complex morphology in left ventricular hypertrophy | |
| Gunawardene et al. | Left atrial posterior wall isolation with pulsed field ablation in persistent atrial fibrillation | |
| Baena-Montes et al. | Electroporation parameters for human cardiomyocyte ablation in vitro | |
| Unland et al. | Find me if you can: first clinical experience using the novel CARTOFINDER algorithm in a routine workflow for atrial fibrillation ablation | |
| Rijks et al. | Left bundle branch area pacing and atrioventricular node ablation in a single-procedure approach for elderly patients with symptomatic atrial fibrillation | |
| Demșa et al. | Persistent left superior vena cava with absent right superior vena cava and discrete subaortic stenosis diagnosed in a patient with sick sinus syndrome: a case report and brief review of the literature | |
| Gardas et al. | The effects of his bundle pacing compared to classic resynchronization therapy in patients with pacing-induced cardiomyopathy | |
| Repp et al. | Opportunities and challenges in catheter-based irreversible electroporation for ventricular tachycardia | |
| Jin et al. | Feasibility of left bundle branch area pacing combined with atrioventricular node ablation in atrial fibrillation patients with heart failure | |
| Deb et al. | Identifying atrial fibrillation mechanisms for personalized medicine | |
| Qiu et al. | Potential application of pulsed field ablation in ventricular arrhythmias | |
| Goanță et al. | Nonischemic super-responders in fusion CRT pacing with normal atrioventricular conduction | |
| Villatore et al. | Autoimmune myocarditis and arrhythmogenic mitral valve prolapse: an unexpected overlap syndrome | |
| Zhao et al. | Pulsed-Field Ablation Using a Novel Ablation-Mapping Integrated System for Pulmonary Vein Isolation—A Preliminary Animal Study | |
| Christie et al. | Trigger and substrate mapping and ablation for ventricular fibrillation in the structurally normal heart | |
| Pierucci et al. | Pulsed Field Energy in Atrial Fibrillation Ablation: From Physical Principles to Clinical Applications | |
| Okólska et al. | Prevalence of arrhythmia in adults after fontan operation | |
| Russo et al. | Comprehensive Cardiovascular Management of Myotonic Dystrophy Type 1 Patients: A Report from the Italian Neuro-Cardiology Network | |
| Wolff et al. | HOT CRT—The Effective Combination of Conventional Cardiac Resynchronization and His Bundle Pacing | |
| Ding et al. | Angiographic Characteristics of the Vein of Marshall in Patients with and without Atrial Fibrillation | |
| Yarkoni et al. | Ganglionated Plexus Ablation Procedures to Treat Vasovagal Syncope |